199 related articles for article (PubMed ID: 15043214)
1. Sugar and spice: viral envelope-DC-SIGN interactions in HIV pathogenesis.
Su SV; Gurney KB; Lee B
Curr HIV Res; 2003 Jan; 1(1):87-99. PubMed ID: 15043214
[TBL] [Abstract][Full Text] [Related]
2. Identification of the DC-SIGN-interactive domains on the envelope glycoprotein of HIV-1 CRF07_BC.
Liao CF; Wang SF; Lin YT; Ho DD; Chen YM
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):831-9. PubMed ID: 21142800
[TBL] [Abstract][Full Text] [Related]
3. Binding of HIV-1 gp120 to DC-SIGN promotes ASK-1-dependent activation-induced apoptosis of human dendritic cells.
Chen Y; Hwang SL; Chan VS; Chung NP; Wang SR; Li Z; Ma J; Lin CW; Hsieh YJ; Chang KP; Kung SS; Wu YC; Chu CW; Tai HT; Gao GF; Zheng B; Yokoyama KK; Austyn JM; Lin CL
PLoS Pathog; 2013 Jan; 9(1):e1003100. PubMed ID: 23382671
[TBL] [Abstract][Full Text] [Related]
4. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.
Arrighi JF; Pion M; Wiznerowicz M; Geijtenbeek TB; Garcia E; Abraham S; Leuba F; Dutoit V; Ducrey-Rundquist O; van Kooyk Y; Trono D; Piguet V
J Virol; 2004 Oct; 78(20):10848-55. PubMed ID: 15452205
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding.
Hong PW; Flummerfelt KB; de Parseval A; Gurney K; Elder JH; Lee B
J Virol; 2002 Dec; 76(24):12855-65. PubMed ID: 12438611
[TBL] [Abstract][Full Text] [Related]
6. DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission.
Geijtenbeek TB; van Kooyk Y
Curr Top Microbiol Immunol; 2003; 276():31-54. PubMed ID: 12797442
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of DC-SIGN on dendritic cells detects tetramers required for ligand binding but no association with CD4.
Bernhard OK; Lai J; Wilkinson J; Sheil MM; Cunningham AL
J Biol Chem; 2004 Dec; 279(50):51828-35. PubMed ID: 15385553
[TBL] [Abstract][Full Text] [Related]
8. Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.
Garcia-Vallejo JJ; Koning N; Ambrosini M; Kalay H; Vuist I; Sarrami-Forooshani R; Geijtenbeek TB; van Kooyk Y
Int Immunol; 2013 Apr; 25(4):221-33. PubMed ID: 23291968
[TBL] [Abstract][Full Text] [Related]
9. Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor.
Tomašić T; Hajšek D; Švajger U; Luzar J; Obermajer N; Petit-Haertlein I; Fieschi F; Anderluh M
Eur J Med Chem; 2014 Mar; 75():308-26. PubMed ID: 24556146
[TBL] [Abstract][Full Text] [Related]
10. Cell type-dependent retention and transmission of HIV-1 by DC-SIGN.
Trumpfheller C; Park CG; Finke J; Steinman RM; Granelli-Piperno A
Int Immunol; 2003 Feb; 15(2):289-98. PubMed ID: 12578859
[TBL] [Abstract][Full Text] [Related]
11. DCIR interacts with ligands from both endogenous and pathogenic origin.
Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
[TBL] [Abstract][Full Text] [Related]
12. Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside.
Varga N; Sutkeviciute I; Guzzi C; McGeagh J; Petit-Haertlein I; Gugliotta S; Weiser J; Angulo J; Fieschi F; Bernardi A
Chemistry; 2013 Apr; 19(15):4786-97. PubMed ID: 23417900
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 gp120 protein downregulates Nef induced IL-6 release in immature dentritic cells through interplay of DC-SIGN.
Sarkar R; Mitra D; Chakrabarti S
PLoS One; 2013; 8(3):e59073. PubMed ID: 23554973
[TBL] [Abstract][Full Text] [Related]
14. Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120.
Hong PW; Nguyen S; Young S; Su SV; Lee B
J Virol; 2007 Aug; 81(15):8325-36. PubMed ID: 17522223
[TBL] [Abstract][Full Text] [Related]
15. Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor.
Snyder GA; Ford J; Torabi-Parizi P; Arthos JA; Schuck P; Colonna M; Sun PD
J Virol; 2005 Apr; 79(8):4589-98. PubMed ID: 15795245
[TBL] [Abstract][Full Text] [Related]
16. Human milk oligosaccharides reduce HIV-1-gp120 binding to dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN).
Hong P; Ninonuevo MR; Lee B; Lebrilla C; Bode L
Br J Nutr; 2009 Feb; 101(4):482-6. PubMed ID: 19230080
[TBL] [Abstract][Full Text] [Related]
17. High-affinity glycopolymer binding to human DC-SIGN and disruption of DC-SIGN interactions with HIV envelope glycoprotein.
Becer CR; Gibson MI; Geng J; Ilyas R; Wallis R; Mitchell DA; Haddleton DM
J Am Chem Soc; 2010 Nov; 132(43):15130-2. PubMed ID: 20932025
[TBL] [Abstract][Full Text] [Related]
18. Short Communication: Inhibition of DC-SIGN-Mediated HIV-1 Infection by Complementary Actions of Dendritic Cell Receptor Antagonists and Env-Targeting Virus Inactivators.
Pustylnikov S; Dave RS; Khan ZK; Porkolab V; Rashad AA; Hutchinson M; Fieschi F; Chaiken I; Jain P
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):93-100. PubMed ID: 26383762
[TBL] [Abstract][Full Text] [Related]
19. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation.
Moris A; Nobile C; Buseyne F; Porrot F; Abastado JP; Schwartz O
Blood; 2004 Apr; 103(7):2648-54. PubMed ID: 14576049
[TBL] [Abstract][Full Text] [Related]
20. Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients.
Nair MP; Mahajan SD; Schwartz SA; Reynolds J; Whitney R; Bernstein Z; Chawda RP; Sykes D; Hewitt R; Hsiao CB
J Immunol; 2005 Jun; 174(11):6617-26. PubMed ID: 15905500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
